West Pharmaceutical Fair Value
WS
The fair market value of WST stock is 327.1 USD. Relative to the market price of 342.705 USD West Pharmaceutical is overvalued by 4.6%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
West Pharmaceutical Valuation
Current WST share ticker price is 342.705 USD.
The fair value level of 327.1 USD can be considered as an effective entry point for long-term investors to start investing in WST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 5% higher its fair value
Current price is 24% higher its minimum value
Current price is 13% lower its maximum value
Market price:
WST stock is overvalued
It means the current price may concern as a Risky Entry Point
West Pharmaceutical Services Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
56.63
2
Median P/E over 5 years
47.9
3
Minimum P/E over 5 years
37.91
4
Earning per share (last 12 months)
6.83 USD
Maximum value
1
x
4
=
386.77 USD
Fair value
2
x
4
=
327.1 USD
Minimum value
3
x
4
=
258.87 USD
West Pharmaceutical Services Inc price metrics
16.12
Annual return (geometric mean)
35.43
Risk (standard deviation) of returns
β
1.01
Beta (volatility compared to market)